DOJ Formally Reschedules FDA-Approved and State-Licensed Medical Marijuana to Schedule III

What Happened

According to U.S. Department of Justice — Office of Public Affairs on April 23, 2026 in Federal — DOJ / DEA, The Department of Justice issued a final order placing FDA-approved marijuana products and cannabis products held under a qualifying state-issued license into Schedule III of the Controlled Substances Act, while maintaining strict federal controls. The primary source is linked in the Source section below; readers are encouraged to review it directly for full context.

Why This Is Trending Now

This is the first federal reclassification of cannabis in more than five decades and immediately changes the tax, banking, and compliance landscape for state-licensed medical operators.

Why Businesses Should Pay Attention

IRC §280E no longer bars ordinary business deductions for covered medical cannabis activity, and DEA registration is now required for state-licensed medical operators.

Practical Considerations

Businesses may want to monitor the status of the underlying rule, filing, proceeding, or announcement as it evolves. Companies may need to evaluate how this development could interact with current contracts, licenses, disclosures, and compliance programs. The issue may raise questions around vendor obligations, reporting timelines, and internal policy updates that warrant discussion with qualified counsel.

Cogent Law Perspective

Cogent Law advises operators on Schedule III transition planning, DEA registration, compliance program design, and negotiating investor and lender documents in the post-rescheduling regime. The best next step is to speak with counsel about the facts specific to your organization.

Key Takeaways

• This is the first federal reclassification of cannabis in more than five decades and immediately changes the tax, banking, and compliance landscape for state-licensed medical operators.
• IRC §280E no longer bars ordinary business deductions for covered medical cannabis activity, and DEA registration is now required for state-licensed medical operators.
• Cogent Law advises operators on Schedule III transition planning, DEA registration, compliance program design, and negotiating investor and lender documents in the post-rescheduling regime.
• Review the primary source from U.S. Department of Justice — Office of Public Affairs for the full record before making any decisions.
• Speak with Cogent Law to discuss how this development may affect your business.

Related Practice Areas